Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

Vilaprisan

Generic Name: Vilaprisan

Drug Type: Small Molecule

Chemical Formula: C_₂₇H_₂₉F_₅O_₄S

CAS Number: 1262108-14-4

Unique Ingredient Identifier: IN59K53GI9

Overview

Vilaprisan has been used in trials studying the treatment of Leiomyoma and Clinical Trial, Phase I.

Background

Vilaprisan has been used in trials studying the treatment of Leiomyoma and Clinical Trial, Phase I.

Indication

No indication information available.

Associated Conditions

No associated conditions information available.

Clinical Trials

Assessment of Safety and Efficacy of Vilaprisan in Subjects With Uterine Fibroids

Phase 3

Withdrawn

Posted: 2018/10/09

Sponsor:Bayer

ID:NCT03699176

Assess Safety and Efficacy of Vilaprisan in Subjects With Endometriosis

Phase 2

Terminated

Posted: 2018/06/29

Sponsor:Bayer

ID:NCT03573336

A Study to Assess the Safety and Efficacy of Vilaprisan in Japanese Subjects With Uterine Fibroids and Heavy Menstrual Bleeding

Phase 3

Terminated

Posted: 2018/03/26

Sponsor:Bayer

ID:NCT03476928

Pharmacokinetics and Safety of Vilaprisan in Renal Impairment

Phase 1

Completed

Posted: 2018/01/26

Sponsor:Bayer

ID:NCT03411980

Assess Safety and Efficacy of Vilaprisan in Subjects With Uterine Fibroids (ASTEROID 3)

Phase 3

Terminated

Posted: 2018/01/17

Sponsor:Bayer

ID:NCT03400943

FDA Approved Products

No FDA products found for this drug

Singapore Approved Products

No Singapore products found for this drug

Related News

No news found

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

Home Terms & Conditions Privacy Policy